194 related articles for article (PubMed ID: 32556286)
1. Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency.
Wu Z; Gao S; Diamond C; Kajigaya S; Chen J; Shi R; Palmer C; Hsu AP; Calvo KR; Hickstein DD; Holland SM; Young NS
Blood Adv; 2020 Jun; 4(12):2656-2670. PubMed ID: 32556286
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.
Katsumura KR; Liu P; Kim JA; Mehta C; Bresnick EH
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2317147121. PubMed ID: 38422019
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function.
Johnson KD; Jung MM; Tran VL; Bresnick EH
Curr Opin Hematol; 2023 Jul; 30(4):117-123. PubMed ID: 37254854
[TBL] [Abstract][Full Text] [Related]
4. GATA2 deficiency and related myeloid neoplasms.
Wlodarski MW; Collin M; Horwitz MS
Semin Hematol; 2017 Apr; 54(2):81-86. PubMed ID: 28637621
[TBL] [Abstract][Full Text] [Related]
5. Perturbed collagen metabolism underlies lymphatic recanalization failure in Gata2 heterozygous deficient mice.
Watanabe-Asaka T; Hayashi M; Harada T; Uemura S; Takai J; Nakamura Y; Moriguchi T; Kawai Y
J Biochem; 2024 Apr; 175(5):551-560. PubMed ID: 38168819
[TBL] [Abstract][Full Text] [Related]
6. A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype-phenotype Association.
Roncareggi S; Girardi K; Fioredda F; Pedace L; Arcuri L; Badolato R; Bonanomi S; Borlenghi E; Cirillo E; Coliva T; Consonni F; Conti F; Farruggia P; Gambineri E; Guerra F; Locatelli F; Mancuso G; Marzollo A; Masetti R; Micalizzi C; Onofrillo D; Piccini M; Pignata C; Raddi MG; Santini V; Vendemini F; Biondi A; Saettini F
J Clin Immunol; 2023 Nov; 43(8):2192-2207. PubMed ID: 37837580
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of GATA2 haplo-insufficiency in a young woman prompted by pancytopenia with deficiencies of B-cell and dendritic cell development.
Sanyi A; Jaye DL; Rosand CB; Box A; Shanmuganathan C; Waller EK
Biomark Res; 2018; 6():13. PubMed ID: 29588856
[TBL] [Abstract][Full Text] [Related]
8. Restricting genomic actions of innate immune mediators on fetal hematopoietic progenitor cells.
Tran VL; Liu P; Katsumura KR; Kim E; Schoff BM; Johnson KD; Bresnick EH
iScience; 2023 Apr; 26(4):106297. PubMed ID: 36950124
[TBL] [Abstract][Full Text] [Related]
9. A mouse model of Zhu-Tokita-Takenouchi-Kim syndrome reveals indispensable SON functions in organ development and hematopoiesis.
Vukadin L; Park B; Mohamed M; Li H; Elkholy A; Torrelli-Diljohn A; Kim JH; Jeong K; Murphy JM; Harvey CA; Dunlap S; Gehrs L; Lee H; Kim HG; Sah JP; Lee SN; Stanford D; Barrington RA; Foote JB; Sorace AG; Welner RS; Hildreth BE; Lim SS; Ahn EE
JCI Insight; 2024 Mar; 9(5):. PubMed ID: 38290089
[TBL] [Abstract][Full Text] [Related]
10. Introduction to a review series on germ line predisposition to hematologic malignancies: time to consider germ line testing.
Cazzola M
Blood; 2023 Mar; 141(13):1509-1512. PubMed ID: 36787501
[No Abstract] [Full Text] [Related]
11. Many signs, one mutation: Early onset of de novo GATA2 deficiency syndrome. A case report.
Blanco ML; Torrent M; Bussaglia E; Badell I; Nomdedéu JF
Clin Case Rep; 2020 Dec; 8(12):3193-3197. PubMed ID: 33363905
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of single-cell RNA sequencing data from healthy human marrow hematopoietic cells.
Zhao X; Gao S; Kajigaya S; Liu Q; Wu Z; Feng X; Zhang F; Young NS
BMC Res Notes; 2020 Nov; 13(1):514. PubMed ID: 33168060
[TBL] [Abstract][Full Text] [Related]
13. Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories.
Johnson KD; Conn DJ; Shishkova E; Katsumura KR; Liu P; Shen S; Ranheim EA; Kraus SG; Wang W; Calvo KR; Hsu AP; Holland SM; Coon JJ; Keles S; Bresnick EH
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32736380
[TBL] [Abstract][Full Text] [Related]
14. Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?
Bresnick EH; Jung MM; Katsumura KR
Blood Adv; 2020 Sep; 4(18):4584-4592. PubMed ID: 32960960
[TBL] [Abstract][Full Text] [Related]
15. MAEA is an E3 ubiquitin ligase promoting autophagy and maintenance of haematopoietic stem cells.
Wei Q; Pinho S; Dong S; Pierce H; Li H; Nakahara F; Xu J; Xu C; Boulais PE; Zhang D; Maryanovich M; Cuervo AM; Frenette PS
Nat Commun; 2021 May; 12(1):2522. PubMed ID: 33947846
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell Transcriptomic Analysis of Hematopoietic Cells.
Strzelecka PM; Ranzoni AM; Cvejic A
Methods Mol Biol; 2021; 2185():135-158. PubMed ID: 33165847
[TBL] [Abstract][Full Text] [Related]
17. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer.
Weber ZT; Collier KA; Tallman D; Forman J; Shukla S; Asad S; Rhoades J; Freeman S; Parsons HA; Williams NO; Barroso-Sousa R; Stover EH; Mahdi H; Cibulskis C; Lennon NJ; Ha G; Adalsteinsson VA; Tolaney SM; Stover DG
Genome Med; 2021 May; 13(1):89. PubMed ID: 34016182
[TBL] [Abstract][Full Text] [Related]
18. Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2-Positive Breast Cancer: A Secondary Analysis of the TRAIN-2 Randomized, Phase 3 Trial.
van der Voort A; van Ramshorst MS; van Werkhoven ED; Mandjes IA; Kemper I; Vulink AJ; Oving IM; Honkoop AH; Tick LW; van de Wouw AJ; Mandigers CM; van Warmerdam LJ; Wesseling J; Vrancken Peeters MT; Linn SC; Sonke GS
JAMA Oncol; 2021 Jul; 7(7):978-984. PubMed ID: 34014249
[TBL] [Abstract][Full Text] [Related]
19. First Experiences with Alpelisib in Clinical Routine: Case Reports from a German Breast Center.
Hester A; Henze F; Travi C; Harbeck N; Wuerstlein R
Breast Care (Basel); 2021 Apr; 16(2):129-134. PubMed ID: 34012367
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
Huang X; He M; Peng H; Tong C; Liu Z; Zhang X; Shao Y; Zhu D; Zhang J; Yin JC; Yang F; Lan C
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
